CDC-Authored Genomics and Precision Health Publications Database
Last data update: Nov 28, 2023. (Total: 4484 publications since 2011)
| Query Trace: all>>Elliot Raizes[CDC Author] |
|---|
| Pretreatment Human Immunodeficiency Virus (HIV) Drug Resistance Among Treatment-Naive Infants Newly Diagnosed With HIV in 2016 in Namibia: Results of a Nationally Representative Study.
Jordan MR , Bikinesi L , Ashipala L , Mutenda N , Brantuo M , Hunt G , Shiningavamwe A , Mutandi G , Beukes A , Beard S , Battey K , Dziuban EJ , Raizes E , Adjei P , Tang A , Giron A , Hong SY . Open Forum Infect Dis 2022 9 (5) ofac102 |
| Drug resistance and use of long-acting ART.
daSilva J , Siedner M , McCluskey S , Chandiwana N , Venter F , Raizes E . Lancet HIV 2022 9 (6) e374-e375 |
| HIV-1 drug resistance mutations among individuals with low-level viraemia while taking combination ART in Botswana.
Bareng OT , Moyo S , Zahralban-Steele M , Maruapula D , Ditlhako T , Mokaleng B , Mokgethi P , Choga WT , Moraka NO , Pretorius-Holme M , Mine MO , Raizes E , Molebatsi K , Motswaledi MS , Gobe I , Mohammed T , Gaolathe T , Shapiro R , Mmalane M , Makhema JM , Lockman S , Essex M , Novitsky V , Gaseitsiwe S . J Antimicrob Chemother 2022 77 (5) 1385-1395 |
| Monitoring emerging HIV drug resistance in sub-Saharan Africa in the era of dolutegravir.
daSilva J , Pals S , Chang J , Hackett S , Godfrey C , Raizes E . J Infect Dis 2021 225 (3) 364-366 |
| HIV drug resistance among adults initiating antiretroviral therapy in Uganda.
Watera C , Ssemwanga D , Namayanja G , Asio J , Lutalo T , Namale A , Sanyu G , Ssewanyana I , Gonzalez-Salazar JF , Nazziwa J , Nanyonjo M , Raizes E , Kabuga U , Mwangi C , Kirungi W , Musinguzi J , Mugagga K , Mbidde EK , Kaleebu P . J Antimicrob Chemother 2021 76 (9) 2407-2414 |
| Finding, treating and retaining persons with HIV in a high HIV prevalence and high treatment coverage country: Results from the Botswana Combination Prevention Project.
Bachanas P , Alwano MG , Lebelonyane R , Block L , Behel S , Raizes E , Ussery G , Wang H , Ussery F , PretoriusHolme M , Sexton C , Pals S , Lasry A , DelCastillo L , Hader S , Lockman S , Bock N , Moore J . PLoS One 2021 16 (4) e0250211 |
| HIV drug resistance profile in South Africa: Findings and implications from the 2017 national HIV household survey.
Moyo S , Hunt G , Zuma K , Zungu M , Marinda E , Mabaso M , Kana V , Kalimashe M , Ledwaba J , Naidoo I , Takatshana S , Matjokotja T , Dietrich C , Raizes E , Diallo K , Kindra G , Mugore L , Rehle T . PLoS One 2020 15 (11) e0241071 |
| Low levels of HIV-1 drug resistance mutations in patients who achieved viral re-suppression without regimen switch: a retrospective study.
Onwuamah CK , Okpokwu J , Audu R , Imade G , Meloni ST , Okwuraiwe A , Chebu P , Musa AZ , Chaplin B , Dalhatu I , Agbaji O , Samuels J , Ezechi O , Ahmed M , Odaibo G , Olaleye DO , Okonkwo P , Salako BL , Raizes E , Yang C , Kanki PJ , Idigbe EO . BMC Microbiol 2020 20 (1) 17 |
| Prevalence of pretreatment HIV drug resistance in Cameroon following a nationally representative WHO survey.
Tchouwa GF , Eymard-Duvernay S , Cournil A , Lamare N , Serrano L , Butel C , Bertagnolio S , Mpoudi-Ngole E , Raizes E , Aghokeng AF . J Antimicrob Chemother 2018 73 (9) 2468-2474 |
| HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing.
Rhee Soo-Yon, Jordan Michael R, Raizes Elliot, Chua Arlene, Parkin Neil, Kantor Rami, Van Zyl Gert U, Mukui Irene, Hosseinipour Mina C, Frenkel Lisa M, Ndembi Nicaise, Hamers Raph L, Rinke de Wit Tobias F, Wallis Carole L, Gupta Ravindra K, Fokam Joseph, Zeh Clement, Schapiro Jonathan M, Carmona Sergio, Katzenstein David, Tang Michele, Aghokeng Avelin F, De Oliveira Tulio, Wensing Annemarie M J, Gallant Joel E, Wainberg Mark A, Richman Douglas D, Fitzgibbon Joseph E, Schito Marco, Bertagnolio Silvia, Yang Chunfu, Shafer Robert W.PloS one 0 (12) e0145772 . PloS one 2015 (12) e0145772 |
- Page last reviewed:Oct 1, 2023
- Page last updated:Nov 28, 2023
- Content source: